IMMUNE RESPONSE CORP·4

Oct 5, 5:57 PM ET

IMMUNE RESPONSE CORP 4

4 · IMMUNE RESPONSE CORP · Filed Oct 5, 2005

Insider Transaction Report

Form 4
Period: 2005-09-30
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2005-09-30$0.46/sh+5,389$2,47929,629 total
Footnotes (1)
  • [F1]Matching company contribution to 401K account.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT